NEW YORK (GenomeWeb News) – The National Cancer Institute said today that it has struck two new partnerships, one with the National Heart, Lung, and Blood Institute and another with the Food and Drug Administration, to develop and support new proteomics research projects through its Office of Cancer Clinical Proteomics Research, or OCCPR.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.